The angiotensin II (Ang II) type 2 receptor (AT 2 ) is a member of the seven-transmembrane domain, G-protein coupled receptor family. This receptor is ubiquitously distributed in the fetus but, in most tissues, its expression dramatically falls in the first few hours after birth. Based on this observation, the hypothesis that this receptor could be involved in fetal development was raised and, over the past ten years, many studies have tried to identify a role for the AT 2 receptor using many different tissues and cell lines. To date, one of the major roles associated with the Ang II AT 2 receptor concerns its ability to induce neuronal differentiation. Indeed, in cells of neuronal origin, activation of the AT 2 receptor was shown to induce neurite outgrowth and elongation, modulate neuronal excitability, promote cellular migration and, in particular conditions, induce neuronal cell death. Regarding its signaling mechanisms, the AT 2 receptor still represents one of the most controversial G-protein coupled receptors since it does not stimulate the production of any of the classical second messengers. This review summarizes knowledge of the functions and the signaling mechanisms involved in the actions of the AT 2 receptor in neurons and cells of neuronal origin. Based on its altered expression in neurological disorders, a role for the AT 2 receptor in control of neuronal plasticity is proposed.
Introduction
The angiotensin II (Ang II) octapeptide, the active component of the renin-angiotensin system, binds and activates two major types of serpentine, seven-transmembrane domain G-protein coupled receptors, namely AT 1 and AT 2 . Most of Ang II's well-known effects, including modulation of blood pressure, control of fluid/electrolyte balance and cellular proliferation, are associated with activation of the AT 1 receptor. The functions of the AT 2 receptor, however, were less well known until recently. During the last decade, the AT 2 receptor has been shown to be involved in the regulation of cell proliferation, programmed cell death (apoptosis), and cellular differentiation; most of these results were obtained from cells of neuronal origin. Observations that in the fetus the AT 2 receptor is widely distributed in many brain structures and steroid-producing glands, such as the adrenal glands or the ovaries (Tanaka et al. 1995 , Breault et al. 1996 , Schutz et al. 1996 , Nuyt et al. 1999 , led to a hypothesis for a role in cellular differentiation. In the adult, AT 2 receptor expression is restricted to the uterus (Nielsen et al. 1997) , ovarian granulosa cells (Pucell et al. 1991 , Yoshimura et al. 1996 , Johnson et al. 1997 , adrenal glands (Belloni et al. 1998 , Wang et al. 1998 and some areas of the brain involved in cognition and behavior (Song et al. 1992 , Lenkei et al. 1996 .
Brain renin-angiotensin system
Early studies from Mendelsohn et al. (1988) and Unger et al. (1988) established, using biochemical and pharmacological approaches, the existence of a renin-angiotensin system in the brain. The various components (angiotensin-converting enzyme, Ang II and Ang II receptors) are found in areas of the brain involved in the regulation of fluid and electrolyte balance and in the regulation of arterial pressure (Severs & Daniels-Severs 1973 , Phillips 1987 , as well as in structures involved in cognition, behavior and locomotion. Interestingly, all of these components, and in particular the AT 2 receptor, are highly expressed during fetal life, suggesting that they could play important roles during development. As reported by Nuyt et al. (1999) based on studies conducted in fetal and neonatal rats, AT 2 receptor mRNA appeared early (as early as embryonic day 13) in the differentiating lateral hypothalamic area, but transiently in various developing/differentiating brain structures. In most areas, ontogeny of AT 2 receptor mRNA expression is highly correlated with the maturation and differentiation of the different areas themselves (as in the cerebellum, inferior olivary complex, and medullary motor nuclei innervating the tongue, perioral, and jaw muscles, where AT 2 receptor expression dramatically diminished in the mature neurons). From studies conducted in cell lines, one can hypothesize that during development activation of the AT 2 receptor is involved in neurite elongation, neuron migration, neuronal death/ survival balance, as well as in the establishment and maintenance of synaptic connections. In the adult rat, the AT 2 receptor was found at high levels in the medulla oblongata (control of autonomous functions), in septum and amygdala (associated with anxiety-like behavior), in the thalamus (sensory perception), in the superior colliculus (control of eye movements in response to visual information) as well as in the subthalamic nucleus and in the cerebellum (areas associated with learning of motor functions) (Song et al. 1992 , Lenkei et al. 1996 . According to Bottari et al. (1992) and our observations in rat cerebellar granule cells in culture (Fig. 1A) , AT 2 receptors are found on neurons, but not on astrocytes or glial cells. The presence of the AT 2 receptor in restricted brain areas of the adult and its wide distribution in the fetus (in many differentiating structures and nuclei) are suggestive of a role in neuronal function and neuronal development respectively. Accordingly, using cells of neuronal origin and models of neuronal regeneration, the AT 2 receptor was found to be involved in the induction of apoptosis and cell differentiation.
AT 2 receptor and neuronal differentiation
Differentiation of cells from neuronal origin required a progression through four essential steps: (1) cellular growth, (2) cellular migration, (3) elongation of axons and dendrites and (4) synaptogenesis (for review see Hatten & Heintz 1995) . Supporting a role for the AT 2 receptor in the development/differentiation of fetal and perinatal brain structures, various studies have shown that its activation with angiotensin II could be involved in at least three steps of the differentiation process: cell growth, migration and elongation of axons and dendrites.
AT 2 receptor and neurite outgrowth
Induction of neurite outgrowth and elongation is one of the best characterized roles of the AT 2 receptor in cells of neuronal origin. We and others have demonstrated that specific activation of the AT 2 receptor induces morphological differentiation of several cell types (Laflamme et al. 1996 , Meffert et al. 1996 . We have shown that NG108-15 cells treated for 3 days with Ang II resulted in an increase in both the number and length of neurites (Fig. 1B, C) . This effect was accompanied by an increase in the levels of polymerized -tubulin and the amounts of microtubule-associated protein, also called mitogen-associated protein (MAP2c), associated with microtubules (Laflamme et al. 1996) , a protein known to stabilize tubulin in a polymerized state, thus actively participating in differentiation (Sanchez et al. 2000) . Similar results have been reported in the pheochromocytomaderived cell line, PC12W (Meffert et al. 1996) . As in NG108-15 cells, treatment of PC12W cells with Ang II promoted neuronal differentiation (characterized by an increase in neurite elongation) (Meffert et al. 1996) . In this model, Ang II-induced neurite outgrowth is also associated with enhanced levels of polymerized -tubulin and MAP2 associated with microtubules (Stroth et al. 1998) , but showed reduced expression of MAP1B (Stroth et al. 1998) and neurofilament M (Gallinat et al. 1997) , two proteins specifically associated with elongation of axons (Gordon-Weeks 1991 , Shea & Flanagan 2001 . Angiotensin II-induced neurite outgrowth was also studied in rat neuronal cells in culture. Activation of the AT 2 receptor in postnatal rat retinal explants (Lucius et al. 1998) and in microexplant cultures from rat cerebellum (Côté et al. 1999) promoted neurite extension. In addition to increased levels of polymerized -tubulin, neurite outgrowth in microexplant cultures of the cerebellum was accompanied by enhanced expression of the neuron-specific III-tubulin and increased levels of tau and MAP2 associated with microtubules (Côté et al. 1999) . Altogether, these results suggest that activation of the AT 2 receptor is associated with important rearrangements of the cytoskeleton.
AT 2 receptor and neuronal migration
Accumulating evidence suggests that Ang II could be involved in the organization of several brain areas. Indeed, it was postulated that high levels of the AT 2 receptor in the inferior olivary and in the cerebellum are associated with neuronal plasticity and development (Jöhren et al. 1998 , Arce et al. 2001 . Within their study on the role of the AT 2 receptor in the induction of neurite outgrowth, Côté et al. (1999) observed that Ang II was able to influence cell migration. Indeed, in cerebellar granular cells cultured in microexplants, blockage of the AT 1 receptor or specific activation of the AT 2 receptor with CGP42112 (a specific AT 2 receptor agonist) remarkably induced migration of neuronal cells away from microexplants (where neurons migrate on glial cells, presumably on specialized structures called Bergmann fibers). Control of cellular migration by the AT 2 receptor was also reported in retinal explants during regeneration (Lucius et al. 1998 ) but the mechanisms involved in this process remain to be determined.
AT 2 receptor and neuronal excitability
Calcium and neuronal excitability play a crucial role during neuronal differentiation, regulating neuronal orientation, guidance and differentiation (Komuro & Rakic 1996 , Rakic et al. 1996 , Komuro & Rakic 1998a . In particular, T-type calcium channels are highly expressed in the early steps of neuronal differentiation, where they are involved in cellular growth and proliferation as well as in protein synthesis, excitability (Spitzer 1991 , Spitzer et al. 2000 , and growth cone guidance (Kater & Mills 1991) . However, their expression decreases as differentiation progresses (Yaari et al. 1987 , McCobb et al. 1989 , Kostyuk et al. 1993 , Schmid & Guenther 1999 . In cells of neuronal origin, activation of the AT 2 receptor was shown to promote changes in the expression of different ion channels leading to modifications in neuronal excitability. In NG108-15 cells, Buisson et al. (1992 Buisson et al. ( , 1995 showed that Ang II induced an inhibition of current amplitude attributed to T-type calcium channels by a mechanism involving activation of an unidentified phosphotyrosine phosphatase and a pertussis toxin (PTX)-insensitive G-protein. On the other hand, in rat brain neuronal cultures Kang et al. (1993) showed that activation of the AT 2 receptor stimulated a delayed-rectifier K + current (I K ) and a transient K + current (I A ) through both a PTX-sensitive G-protein (G i ) and PP2A, a serine/ threonine phosphatase (Kang et al. 1994) . In this model, activation of PP2A was mediated by phospholipase A 2 (PLA 2 ) activation and arachidonic acid release (Zhu et al. 1998) . Physiologically, AT 2 -induced activation of potassium currents is associated with a reduction in the length of action potential as well as with a shortening of the refractory period, both of which lead to an increase in membrane excitability (promoting an enhanced firing rate) (Xiong & Marshall 1994 , Zhu et al. 2001 (Fig. 2) .
AT 2 receptor and neuronal regeneration
Apart from its transient expression in many structures during development, expression of the AT 2 receptor increases after cellular damage suggesting a role in wound healing. Indeed, myocardial infarction (Nio et al. 1995) , lesions in the nervous system or axotomy of dorsal root ganglia and sciatic or optic nerves induced a substantial increase in AT 2 receptor expression (Lucius et al. 1998 ) the latter of which was shown to be associated with Ang II-induced axonal regeneration (Lucius et al. 1998) . Accordingly, Ang II and CGP42112 (a specific AT 2 receptor agonist) increased the number of neuronal fibers crossing the lesion site (Lucius et al. 1998) , thus providing evidence for a neurotropic action of Ang II in the central nervous system. Mechanisms involved in these AT 2 -mediated effects are still unidentified, but probably involve signals that promote neuronal survival, polymerization and/or reorganization of microtubules and actin filaments, in addition to cell migration.
AT 2 receptor and neuronal apoptosis
Recently, many studies have focused on the role of the AT 2 receptor in apoptosis. It is well known that, in many cell types, serum-starvation induces apoptosis which can be rescued by the addition of neurotropic factors, such as nerve growth factor (NGF) (Pittman et al. 1993) or insulin (Parrizas et al. 1997) . Interestingly, it was found that neurotropic factor-induced rescue from apoptosis can be blocked by Ang II in cells expressing the AT 2 receptor. Indeed, in PC12W cells, a cell line of neuronal origin, activation of the AT 2 receptor was shown to reverse the protective effects of NGF (Yamada et al. 1996) and to inhibit insulin receptor signaling (Elbaz et al. 2000) , both effects associated with induction of apoptosis. The pro-apoptotic effects of the AT 2 receptor were also reported in many other cell types such as vascular smooth muscle cells (Cui et al. 2001) , ovarian granulosa cells (Tanaka et al. 1995) , rat neuronal cells in culture (Shenoy et al. 1999) , and cells from the fetal zone of the human adrenal gland (Chamoux et al. 1999) . Based on the latter observations, it would appear paradoxical that activation of the AT 2 receptor can, in a same cell line (PC12W cells), induce different responses such as apoptosis (Yamada et al. 1996 , Elbaz et al. 2000 and differentiation (Meffert et al. 1996 ). An important difference is observed between the experimental conditions used to study these two functions: while the former is conducted in the absence of serum, the latter is induced in a serum-containing medium. These observations suggest that the effect of the AT 2 receptor is highly sensitive (or dependent) on the cellular environment. It can thus be hypothesized that the AT 2 receptor cooperates with several proteins such as growth factor receptors or integrins, to mediate its differentiating effect.
Signaling mechanisms associated with the AT 2 receptor
An up-to-date overview on the AT 2 receptor coupling
Signaling mechanisms associated with activation of the AT 2 receptor are still a matter of debate. One of the most controversial features regarding the AT 2 receptor is its functional coupling to a heterotrimeric G-protein. Even if the AT 2 receptor shares similarities with other seven-transmembrane domain receptors, unlike most of them its affinity for its ligand, the Ang II octapeptide, is unaffected in the presence of GTP S, a non-hydrolysable analog of GTP (Bottari et al. 1991 , Pucell et al. 1991 , Buisson et al. 1995 . However, it should be mentioned that the AT 2 receptor displays different sensitivity to GTP analogs, depending on the brain structure where it is expressed (Tsutsumi & Saavedra 1992) . All these data suggest that the AT 2 receptor could be differentially coupled, since only one isoform has been cloned (Kambayashi et al. 1993 , Mukoyama et al. 1993 ). Moreover, it was shown that the AT 2 receptor is not coupled to any of the classical second messengers (cyclic adenosine monophosphate, Ca 2+ , inositol phosphates), thus suggesting that it does not activate G s or G q proteins (Leung et al. 1992 , Webb et al. 1992 . Some studies have demonstrated, however, that signaling mechanisms of the AT 2 receptor were associated with activation of a PTX-sensitive G-protein. Indeed, several groups showed, using in vitro reconstitution studies, that the AT 2 receptor can physically associate with different isoforms of G i subunits (Hansen et al. 2000) , in particular G i2 (Zhang & Pratt 1996 , Sasamura et al. 2000 and G i3 (Zhang & Pratt 1996) .
Signaling pathways of the AT 2 receptor associated or not with G i subunits are reported in Table  1 . Among the effects associated with the AT 2 receptor via activation of G i proteins are the expression of the phosphatase MAP kinase phosphatase-1 (MKP-1) in PC12W and in vascular smooth muscle cells (Hayashida et al. 1996 , Yamada et al. 1996 , Horiuchi et al. 1997 , activation of potassium channels in neurons (Kang et al. 1994) , growth inhibition of NIH3T3 cells (Ozawa et al. 1996) , and cGMP production during neuronal differentiation of NG108-15 cells (Gendron et al. 2002) . PTX-insensitive effects include inhibition of T-type calcium currents (Buisson et al. 1995) as well as activation of the tyrosine phosphatase SHP-1 (SH2 domain containing phosphatase 1) (Bedecs et al. 1997 , Elbaz et al. 2000 , Shibasaki et al. 2001 involved in the AT 2 -mediated inhibition of Shibasaki et al. (2001) different tyrosine kinase receptors and in the AT 2 -induced apoptosis (Nouet & Nahmias 2000 , Cui et al. 2001 . In COS-7 cells expressing the AT 2 receptor, Feng et al. (2002) recently demonstrated that the AT 2 receptor couples to G s subunits. The AT 2 receptor was constitutively associated with SHP-1 and a G s subunit to form an inactive complex. After Ang II application, the complex (AT 2 receptor and G s /SHP-1) dissociates and SHP-1 is activated. Activation of SHP-1 was shown to be independent of G and G s protein activity, suggesting a scaffolding role for G-proteins in AT 2 -mediated signal mechanisms. This study was the first to propose that the AT 2 receptor could physically associate with G s subunits.
AT 2 receptor-induced neuronal apoptosis
In addition to signaling cascades participating in AT 2 receptor-induced neuronal differentiation, cellular mechanisms involved in the induction of apoptosis by Ang II have also been extensively studied. Induction of apoptosis by the AT 2 receptor involved an inhibition of signals from different neurotropic factor receptors (NGF, epidermal growth factor (EGF), insulin and fibroblast growth factor (FGF)). In serum-starved PC12W cells, Yamada et al. (1996) demonstrated that AT 2 -induced apoptosis implicated an inhibition of NGF-stimulated p42/p44 mapk . In this model, activation of the AT 2 receptor was associated with an increase in the expression of MKP-1 (a phosphatase with dual specificity). This enhanced expression of MKP-1 was responsible for the observed inactivation of p42/p44 mapk (Yamada et al. 1996) and Bcl-2, an anti-apoptotic protein (Horiuchi et al. 1997) . In cultured newborn rat hypothalamus and brain stem neurons, activation of the AT 2 receptor enhanced neuronal apoptosis induced by UV radiation. This effect of the AT 2 receptor involved activation of PP2A by a PTX-sensitive mechanism (Shenoy et al. 1999) .
In non-neuronal cells, induction of apoptosis by the AT 2 receptor can also involve activation of SHP-1. SHP-1 is implicated in the AT 2 -dependent inhibition of phosphorylation and signaling of EGF, FGF, insulin and AT 1 receptors (Bedecs et al. 1997 , Lehtonen et al. 1999 , Elbaz et al. 2000 , Cui et al. 2001 , Shibasaki et al. 2001 . Further investigations will be needed to identify the complete mechanisms of SHP-1 activation by the AT 2 receptor as well as its role in cellular apoptosis.
The MAP kinase (MAPK) pathway and differentiation
Over the past five years, in our goal to elucidate AT 2 receptor involvement in Ang II-induced neuronal differentiation, we and others have investigated signaling mechanisms activated by this receptor. In NG108-15 cells, we have found that specific activation of the AT 2 receptor induced an increase in p42/p44 mapk activities (Gendron et al. 1999) . Similar results were obtained in PC12W (Stroth et al. 2000) as well as in non-neuronal COS-7 (Hansen et al. 2000) and NIH3T3 cells (De Paolis et al. 2002) overexpressing the AT 2 receptor. In both NG108-15 (Gendron et al. 1999) and PC12W cells (Stroth et al. 2000) , Ang II-induced p42/p44 mapk activation appears essential for the induction of neurite outgrowth.
In contrast to the AT 1 receptor, activation of the MAPK cascade via the AT 2 receptor is delayed, but sustained, as seen with NGF in PC12W cells (Yaka et al. 1998 , York et al. 1998 . Surprisingly, concomitantly with AT 2 -induced p42/p44 mapk activation, a decrease in the activity of p21 ras is observed (Gendron et al. 1999) . Accordingly, expression of a dominant negative mutant form of p21 ras (RasN17) in NG108-15 cells failed to impair the effect of Ang II on p42/p44 mapk (Gendron et al. 1999) . This observation was the first to document that inhibition of Ras could be associated with neurite elongation.
As illustrated in Fig. 3 , we have recently shown that activation of the AT 2 receptor by Ang II and CGP42112 was followed by stimulation of p21 rap1 and B-Raf activities. Moreover, expression of RapN17 (a dominant negative mutant of p21 rap1 ) or Rap1 GAP (a natural, specific inhibitor of Rap1) completely blocked both AT 2 -induced p42/p44 mapk activation and neurite outgrowth. These observations indicate that the related Ras/Raf-1, namely Rap1/B-Raf, is involved in the AT 2 receptor signaling mechanisms leading to morphological neuronal differentiation (Gendron et al. 2003) . In several models, such as PC12W cells stimulated Figure 3 Pathways involved in the AT 2 -induced neuronal differentiation. The Ang II AT 2 receptor induction of neurite outgrowth and elongation involves at least two distinct, independent, but complementary pathways. First, after binding of Ang II, the activated AT 2 receptor rapidly inactivates p21 ras and activates the Rap1-B-Raf pathway, leading to a delayed p42/p44 mapk phosphorylation. Another pathway involving the NO/sGC/cGMP cascade of signaling is also necessary to observe neurite outgrowth. Stimulation of these two parallel pathways could modulate gene expression and the phosphorylation state of different microtubule-associated proteins (MAPs) to control microtubule stability/dynamic responsible for neurite elongation. NOS, nitric oxide synthase; NO, nitric oxide; sGC, soluble guanylyl cyclase; MEK, mitogen-activated protein kinase kinase; unP-MAPs, unphosphorylated MAPs; P-MAPs, phosphorylated MAPs. CGP42112, an agonist of the AT 2 receptor.
with NGF, cAMP and cAMP-activated proteins (such as protein kinase A (PKA)) are required for activation of p21 rap1 and p42/p44 mapk (York et al. 1998) . However, in NG108-15 cells, we demonstrated that dbcAMP and forskolin did not stimulate Rap1 or p42/p44 mapk activities. Furthermore, addition of H-89, an inhibitor of PKA, or Rp-8-Br-cAMPS, an inactive cAMP analog, failed to impair p42/p44 mapk activity and neurite outgrowth induced by Ang II. These observations indicate that the AT 2 signaling is independent of cAMP, and further indicate that neurite elongation induced by cAMP did not involve the Rap1/B-Raf pathway of signaling, at least in the NG108-15 cells (Hamprecht et al. 1985 , Beaman-Hall & Vallano 1993 , Cowley et al. 1994 , Laflamme et al. 1996 . The mechanisms involved in the AT 2 -induced Rap1/B-Raf activation remain unclear but it could be hypothesized that the AT 2 receptor transactivates other receptors, such as growth factor receptors. In fact, we and others have demonstrated that activation of p42/p44 mapk requires the presence of serum (rich in growth factors) in the culture medium (Gendron et al. 1999 , Hansen et al. 2000 , suggesting that at least one as yet unidentified growth factor participates in the initial actions of the AT 2 receptor, such as activation of Rap1.
The nitric oxide/cGMP pathway and differentiation
Previous studies have reported that Ang II, through the AT 2 receptor, is able to induce nitric oxide (NO) production and cGMP accumulation in different models such as the kidney (Siragy & Carey 1996 , the aorta (Maeso et al. 1996 , Gohlke et al. 1998 , vascular smooth muscle cells from transgenic mice overexpressing the AT 2 receptor (Tsutsumi et al. 1999) , and NG108-15 cells (Schelman et al. 1997 , Côté et al. 1998 . Interestingly, NO, when produced at low levels, is known to induce neuronal differentiation of different cell types such as PC12W (Poluha et al. 1997 , Phung et al. 1999 . In NG108-15 cells, we showed that application of NO donors in the culture medium was sufficient to induce neurite outgrowth and elongation (Côté et al. 1998) . In these cells, AT 2 -induced differentiation involved activation of the neuronal NO synthase (nNOS) and cGMP production (G i -dependent). Indeed, neurite elongation was abolished when the NO signaling cascade was inhibited at the level of nNOS, soluble guanylyl cyclase (sGC) or PKG. Our results demonstrated that this cascade of signaling is involved in neurite outgrowth and elongation as well as in growth cone maturation (Gendron et al. 2002) .
In NG108-15 and in PC12W cells, MAPK activation is an essential event for neurite elongation (Gendron et al. 1999 , Stroth et al. 2000 . For this reason, it has been hypothesized that the NO cascade of signaling could be involved in the activation of p42/p44 mapk . However, our results indicate that the two pathways -Rap1/B-Raf/ MAPK and NO/cGMP/PKG -are necessary but act in an independent, parallel manner to induce morphological changes, possibly mediating microtubule dynamics (Fig. 3) .
From apoptosis to neurite elongation
As outlined in this review, the AT 2 receptor is involved in and/or controls important steps of differentiation. Indeed, Ang II and the AT 2 receptor activate migration, controlled cell death, and neurite elongation.
In the developing brain, after migration is completed and cells have reached their appropriate location, more than 50% of undifferentiated neuronal cells will die by an apoptosis-mediated process (Hatten & Heintz 1995 , Huang & Reichardt 2001 , Valverde 2002 . During this period of differentiation of various brain areas and layers, only cells expressing appropriate receptors for neurotropic factors, and cells adequately stimulated by those factors will survive (Green & Evan 2002) . For example, in the absence of NGF, sympathetic neurons expressing both AT 2 and TrkA receptors undergo an apoptosis program (Yamada et al. 1996) . In the presence of NGF, cells survive and undergo a differentiation process characterized by neurite elongation of both axons and dendrites (Valtorta & Leoni 1999 , Tang 2001 , Bokel & Brown 2002 , Milner & Campbell 2002 , Nikolic 2002 . These functions of survival, migration and elongation are controlled by specific intracellular signaling cascades, activated not only by neurotropic factors, but also by hormones, such as pituitary adenylate cyclase-activating polypeptide (PACAP) (Vaudry et al. 2002) II, through the AT 2 receptor. Moreover, specific interactions between cells and the surrounding matrix components, through integrins and adhesion factors, are also important to integrate various intracellular cascades (Milner & Campbell 2002) necessary to control cell behavior. Indeed, on plastic, activation of the AT 2 receptor promotes migration in NG108-15 cells (Côté et al. 1999) , while on fibronectin, the AT 2 receptor inhibits migration in smooth muscle cells (Chassagne et al. 2002) .
Lessons from the AT 2 receptor alterations: a role for the AT 2 receptor in the developing brain
Knockout mice
In 1995, a mouse model lacking the gene encoding the AT 2 receptor was generated (Hein et al. 1995 , Ichiki et al. 1995 . Studies from these knockout mice reinforced the hypothesis that the AT 2 receptor plays a role in neuronal development. In fact, even if these mutant mice appeared to develop normally, significantly more cells were found in many brain structures (cortex, hippocampus, amygdala, thalamus) (von Bohlen und Halbach et al. 2001) . Based on the roles of the AT 2 receptor described in cells of neuronal origin, it could be hypothesized that the increase of cells in these structures could be the result of the combination of an impaired growth arrest, diminished apoptosis, and/or a reduction of cell migration. The AT 2 -deficient mice suffer from perturbations in exploratory behavior and locomotor activity (Hein et al. 1995 , Ichiki et al. 1995 , as well as an anxiety-like behavior (Okuyama et al. 1999) , impaired drinking responses (Hein et al. 1995) , and hypersensitivity to Ang II on blood pressure and sodium excretion (Siragy et al. 1999) . Altogether, these results demonstrated that the AT 2 receptor plays an important role in the development and in the maturation of various brain structures.
In the adult rat, Braszko (2002) recently reported that inhibition of the AT 2 receptor with PD123319 (a specific AT 2 receptor antagonist) abolished the Ang II-induced acquisition of conditioned avoidance responses. These results strongly support the hypothesis that, in addition to a role during development, the AT 2 receptor may also be involved in cognitive processes in the adult.
AT 2 receptor expression in neurological disorders
Over the last decade, it has been found that the levels of expression of the AT 2 receptor were altered in specific areas of the brain in the course of different neurological disorders. For example, Ge and Barnes (1996) found that AT 2 receptor expression is diminished in Parkinson's disease (caudate nucleus and cerebellum) but is enhanced in Huntington's disease (caudate nucleus). In Alzheimer's disease, the temporal cortex of the adult brain showed an increased expression while the hippocampus displayed a decreased expression of the AT 2 receptor. These results suggest that the AT 2 receptor may play an important role in maintaining functions of the human brain.
AT 2 in mental retardation
Recently, Vervoort et al. (2002) have published results that show that mutations in the Agtr2 gene correlate with the development of human X-linked mental retardation. Indeed, 9 patients with X-linked mental retardation had mutations in the Agtr2 gene associated with decreased expression of the AT 2 receptor, including a complete loss of expression in a woman with an IQ of 44. Again, these observations support the hypothesis that the AT 2 receptor is required for brain development and for the maintenance of neuronal connections involved in learning and memory.
Conclusions and perspectives
As described in this review, the role of the AT 2 receptor of Ang II in neuronal differentiation and brain development is now well documented. Indeed, a number of studies report the role of the AT 2 receptor in neurite elongation, neuronal excitability and axonal regeneration. Over the past 5 years, important progress has been made regarding elucidation of the signaling mechanisms associated with neurite outgrowth, neuronal differentiation and brain development. The increased knowledge of the mechanisms of action of the AT 2 receptor will certainly contribute to a better understanding of the role of Ang II in the brain, particularly in relation to several neurological disorders (Alzheimer, Huntington, Parkinson, mental retardation). However, the earliest events associated with activation of the AT 2 receptor remain unclear. Apart from some effects which are sensitive to pertussis toxin (see Table 1 ) and the recently described interaction with a G s / SHP-1 complex (Feng et al. 2002) , immediate partners of the AT 2 receptor remain to be determined. Although activation of the AT 2 receptor clearly stimulates neurite outgrowth, the cellular targets are not yet clearly identified. Several questions concerning microtubule polymerization and AT 2 signaling partners leading to MAP2, MAP1B and tau phosphorylation remain unanswered.
Because of its correlation with some neurological disorders, it could be expected that the effects of the AT 2 receptor on the different steps of neurite elongation may also play an important role in maintaining/controlling the neuronal plasticity necessary to maintain appropriate synapse connections and plasticity (Arendt 2001 , Segal 2002 . Taken together, these observations concerning roles for the AT 2 receptor in neuronal functions (differentiation, migration, regeneration), as well as involvement in neurological disorders, contribute to reinforce the hypothesis that activation of this receptor involves important rearrangements of at least microtubule networks as witnessed by neurite growth and elongation. The challenge regarding elucidation of the signaling mechanisms associated with the AT 2 receptor will now be to identify the cytoskeletal targets that control dynamic structures at the growth cone level and the stability of the microtubule axon shaft.
